$3.11
▲ +2.0% Today
as of Sep 4, 16:47 ET
Last 30 days
Recent Press Releases & News
CVRx Responds to Letter from Pointillist Family Office
CVRx Announces Devoted Health Medicare Advantage Coverage Policy for Barostim Therapy
CVRx (CVRX) Q2 2026 Earnings Call Transcript
Overview
52-week range
$2.20
$11
10% of range
Avg surprise (last 3)
-0.8%
Avg reaction (last 2)
+2.7%
100% positive
Latest IV / EM
220%
EM ±37.8% · $3 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.53 | — | — | — | — | financials |
| Mon May 11, 2026 | Mar/2026 | $-0.50 | $-0.51 | +2.0% | +5.7% | +1.3% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.49 | — | — | — | — | financials |
| Mon Aug 4, 2025 | Jun/2025 | $-0.57 | $-0.52 | -9.6% | — | — | earnings |
| Thu May 8, 2025 | Mar/2025 | $-0.53 | $-0.56 | +5.4% | — | +4.0% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.57 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.65 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-1.04 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.43 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.56 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.55 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $16M | $15M | — | $15M | $14M | $12M | — | $13M |
| Cost of revenue | $2M | $2M | — | $2M | $2M | $2M | — | $2M |
| Gross profit | $14M | $13M | — | $13M | $11M | $10M | — | $11M |
| Operating income | $-13M | $-12M | — | $-12M | $-14M | $-13M | — | $-13M |
| Net income | $-14M | $-13M | — | $-13M | $-15M | $-14M | — | $-13M |
| EPS (diluted) | $-0.53 | $-0.50 | — | $-0.49 | $-0.57 | $-0.53 | — | $-0.57 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $65M | $72M | $76M | $85M | $95M | $103M | $106M | $100M |
| Inventory | $13M | $12M | $12M | $11M | $12M | $12M | $12M | $12M |
| Total current assets | $89M | $97M | $102M | $108M | $116M | $126M | $130M | $124M |
| Total assets | $92M | $100M | $105M | $111M | $120M | $130M | $133M | $128M |
| Long-term debt | $59M | $58M | $50M | $49M | $49M | $49M | $49M | $49M |
| Total liabilities | $72M | $71M | $65M | $63M | $62M | $60M | $62M | $62M |
| Total equity | $20M | $29M | $39M | $48M | $58M | $69M | $71M | $65M |